自我耐受性和免疫抑制药物FK506如何防止B细胞线粒发生
R Glynne1, S Akkaraju, J I Healy
1Department of Microbiology and Immunology, Beckman Center, Stanford University, California 94305, USA.
Nature
|February 25, 2000
概括
新的研究解释了B细胞无能性如何通过识别参与预防淋巴细胞增殖的基因导致免疫耐受性. 这可能会导致更好的免疫抑制剂用于移植排斥,自身免疫性疾病和过敏.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 目前的免疫抑制剂,如FK506和环素向成熟的淋巴细胞,以防止移植排斥,自身免疫性疾病和过敏.
- 这些药物抑制淋巴细胞增殖,但不会诱导长期耐受性,需要慢性使用并引起副作用.
- 了解周边耐受性的生理机制为开发改进的药理干预提供了一条道路.
研究的目的:
- 为了提供一个分子解释的损失在外围B细胞 anergy中mitogenic反应,免疫耐受性的一个关键方面.
- 识别通过自我抗原暴露调节的基因,有助于耐受性.
- 评估FK506对耐受性和激活的分子通路的影响.
主要方法:
- 利用基因表达阵列来分析外围B细胞 anergy 中的分子变化.
- 研究了由自我抗原暴露引起的基因表达模式.
- 评估了FK506对依赖的耐受性途径和淋巴细胞激活的影响.
主要成果:
- 自抗原暴露诱导的基因负面调节信号和转录,但不是增殖基因,在B细胞 anergy.
- FK506干扰了依赖的耐受性机制,并且抑制了激活反应的比预期的更小一部分.
- 确定了许多与自我耐受性相关的新型基因,为这个过程提供了分子签名.
结论:
- 这项研究阐明了B细胞无能性的分子基础,揭示了参与耐受性诱导的特定基因组.
- 研究结果表明,目前的免疫抑制剂,如FK506,不完全阻断淋巴细胞激活,并干扰耐受性途径.
- 这项研究为开发下一代免疫抑制剂提供了分子框架,可以选择性地阻止淋巴细胞激活,而不会影响周围耐受性.
相关概念视频
Cell-mediated Immune Responses
64.7K
Overview
64.7K
Mitogens and the Cell Cycle
6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Special Features of Adaptive Immunity
3.7K
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
3.7K
Cytotoxic T Cells-mediated Immune Response
7.0K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.0K
B Cell Activation and Differentiation
14.4K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
14.4K


